A Rash Decision: Mycoplasma-Induced Mucositis in a Young Adult

TL;DR

This paper describes a case of a young adult with a rare mucocutaneous syndrome caused by Mycoplasma pneumoniae, emphasizing the importance of accurate diagnosis to avoid mismanagement.

Contribution

The paper contributes a clinical case highlighting Mycoplasma pneumoniae-induced rash and mucositis (MIRM) as a distinct and diagnosable condition.

Findings

A 24-year-old male developed fever, cough, and mucocutaneous symptoms consistent with MIRM.

The case met proposed diagnostic criteria for MIRM without evidence of skin detachment.

Early differentiation from similar conditions like Stevens-Johnson syndrome is critical for proper treatment.

Abstract

Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a distinct emerging clinical entity typically affecting adolescents and adults after a respiratory infection from Mycoplasma pneumoniae. Other known mucocutaneous complications include Stevens-Johnson syndrome, erythema multiforme, and toxic epidermal necrolysis. We present the case of a 24-year-old male patient who developed fever and cough followed by a rapidly evolving mucocutaneous syndrome characterized by oral mucositis, bilateral conjunctivitis, and vesiculobullous skin lesions affecting the palms, soles, and trunk with no evidence of skin detachment. These findings meet the proposed diagnostic criteria for MIRM. This case highlights the importance of recognizing MIRM as a distinct diagnostic entity to guide targeted antimicrobial therapy and avoid unnecessary morbidity associated with misdiagnosis and inappropriate treatment. Early differentiation from Steven-Johnson syndrome and toxic epidermal necrolysis is critical for optimal patient outcomes.

Figures